industry dating back to a 1982 financial position at Bayer , Kley has vast experience that should serve Merck KGaA ..... the firm. Merck KGaA operates two main divisions, pharmaceuticals and chemicals. In the pharmaceutical group, branded
declines in Betaseron, a top drug for Bayer .Both the material science and the ..... differentiation from the older version. Bayer is in the midst of launching several ..... drugs that hold blockbuster potential. Bayer 's entrenchment in biologics helps
FRANKFURT, Nov 22 (Reuters) - Bayer HealthCare has received approval from Japan's Ministry of Health to treat macular edema secondary to central retinal vein occlusion (CRVO) with its Eylea eye...
FRANKFURT, Nov 22 (Reuters) - Bayer HealthCare has received approval from Japan's Ministry of Health to treat macular edema secondary to central retinal vein occlusion (CRVO) with its Eylea eye medication, the company said on Friday.
Nov 21 (Reuters) - Bayer AG : * JP Morgan raises price target to 112 euros from 100 euros; rating overweight For a summary of rating actions and price target
FRANKFURT, Nov 15 (Reuters) - Bayer AG : * Says Bayer receives approval for new cancer drug xofigo * Says receives EU approval for new cancer drug xofigo for adults with
Bayer 's ( BAYRY ) Q3 EBITDA comes in at €1.984B (+7.6% Y/Y), well ahead ..... flat Y/Y), missing estimates by around €200M. Growth in the pharmaceuticals business grows 3.1%, driven by Xarelto, Eylea, Stivarga, and Xofigo
FRANKFURT, Oct 31 (Reuters) - Bayer , Germany's largest drugmaker, posted a 7.7 percent gain in adjusted core earnings, helped by strong sales growth of newly introduced pharmaceuticals .
OncoMed Pharmaceuticals ( OMED ) starts a Phase 1b dose escalation trial for vantictumab (with paclitaxel ..... Phase 1 trials of vantictumab this year. ( PR ) The company is developing the drug with Bayer ( BAYZF ). Post your comment!
VRX Dysport), we think Merz Pharmaceuticals ' launch of Xeomin in 2013 will ..... RHHBY Lucentis and Regeneron/ Bayer 's REGN/BAYRY Eylea in the ..... Allergan's drugs, such as eye pharmaceuticals and skin ointments, face limited